FDBusiness.com

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment

 Breaking News
  • Record High Number of New UK-based Wine Producers Opening The number of new wine producers opening within the UK in a year hit a record high last year with 80 new wine producers starting up – a rise of 25% from 64 in 2016, and more than double the 36 that opened five years ago, according to research by chartered accountants UHY Hacker Young [...]...
  • Mondelēz International Names New Chief Financial Officer Mondelēz International has announced that Luca Zaramella, Senior Vice President of Corporate Finance and a 20-year veteran of the company, will become EVP, Chief Financial Officer (CFO), effective August 1, 2018. As CFO, Zaramella will be responsible for the oversight of the company’s global Finance, Information and Technology Solutions and shared services functions. He will report directly [...]...
  • We’ll Pay Extra For More Protein, Say South American Consumers Nearly two thirds of shoppers in South America are willing to pay extra for a food or beverage product that is higher in protein, according to a survey commissioned by Arla Foods Ingredients. Researchers from Lindberg International asked 4,000 consumers in Argentina, Brazil and Colombia if they would spend more on buying a product if it [...]...
  • Nestlé and XPO Logistics Build a Digital Warehouse of the Future in the UK Nestlé, the world’s largest food and drink company, and XPO Logistics, a leading global provider of transport and logistics solutions, are co-creating a 638,000-square-foot distribution center at the new SEGRO East Midlands Gateway Logistics Park in Leicestershire, UK. The facility, a digital warehouse of the future, will be occupied predominantly by Nestlé for its consumer [...]...
  • Bord Bia’s 2018 Brexit Barometer Results The Irish Government has launched the Bord Bia 2018 Brexit Barometer, a comprehensive survey of 117 Irish food, drink and horticulture companies, representing 48% of the sector’s exporters to the United Kingdom. Over 100 senior industry representatives attended the launch in Bord Bia to hear the report findings. The purpose of the Brexit Barometer is to assess [...]...

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment

New Research by Nestle Health Science to Help Improve Inflammatory Bowel Disease Treatment
May 24
11:52 2012

Prometheus Laboratories, a company acquired by Nestle Health Science, has presented new research that confirms the effectiveness of its new diagnostic test designed to improve treatment management for patients with inflammatory bowel disease (IBD). The test is designed to predict inflammatory bowel disease activity and measure the impact of infliximab, a drug used by patients to help prevent inflammation.

Over time, some of them become less responsive to the drug so it is vital for medical practitioners to be able to diagnose this early on so a different course of treatment can be found. The data, reported by the company at this year’s Digestive Disease Week event in San Diego, in the United States, provides evidence of the effectiveness of the company’s new monitoring test which will be launched later this year.

Nestle Health Science acquired Prometheus Laboratories mid 2011. Prometheus specialises in diagnostics and in-licensed specialty pharmaceuticals in gastroenterology and oncology and focuses on conditions such as IBD.

The test should help ensure patients with chronic inflammatory bowel disorders can be treated effectively. These include ulcerative colitis and Crohn’s disease which typically cause abdominal pain, fever and diarrhoea.

IBD is clinically difficult to diagnose and manage, with many patients requiring long term medical care. Currently the disease has no cure.  Recent statistics from the Crohn’s and Colitis Foundation of America estimate that about 1.4 million people in the country suffer from the disease.

The new research into how to manage IBD supports Nestlé Health Science’s long-term vision and ambition to develop science-based personalised nutritional solutions. The company, established last year, is a wholly-owned subsidiary of Nestlé.

Building on its core HealthCare Nutrition business, Nestlé Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or special challenges of different life stages. Nestlé Health Science has access to external scientific and technological know-how through Nestlé’s innovation network as well as a number of venture capital funds in which the group has interests.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • June 25, 2018Packaged., The 7th Global Summit
  • September 5, 2018Int'l Food Products and Processing Technologies Exhibition (WorldFood Istanbul)
  • September 15, 2018iba
  • September 25, 2018PPMA Show 2018
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements